New drug shows promise for stubborn thyroid eye disease
NCT ID NCT06269393
First seen Apr 07, 2026 · Last updated May 19, 2026 · Updated 9 times
Summary
This study tested a new medicine called IBI311 for people with thyroid eye disease that did not get better with steroids. The medicine is an antibody that blocks a protein linked to eye bulging and inflammation. The study involved 53 adults and measured if the treatment could reduce eye bulging by at least 2 millimeters without worsening the other eye.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID ASSOCIATED OPHTHALMOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.